Abstract

BackgroundLittle is known about the comparative effectiveness of multiple sclerosis (MS) disease-modifying therapies (DMTs) on patient-reported outcomes in MS. We compared the effects of natalizumab to other DMTs in relation...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Comorbidities are prevalent and detrimental for employment outcomes in people of working age with multiple sclerosis
Jing Chen ... Ingrid Van Der Mei
Multiple Sclerosis | VOL. 26
Jing Chen, et. al.Jing Chen ... Ingrid Van Der Mei
06 Sep 2019
Estimating MS-related work productivity loss and factors associated with work productivity loss in a representative Australian sample of people with multiple sclerosis
Jing Chen ... Andrew J Palmer
Multiple Sclerosis | VOL. 25
Jing Chen, et. al.Jing Chen ... Andrew J Palmer
18 Jun 2018
Changes in patient-reported outcomes between continuers and discontinuers of disease modifying therapy in patients with multiple sclerosis over age 60
Le H Hua ... Nicolas R Thompson
Multiple sclerosis and related disorders | VOL. 30
Le H Hua, et. al.Le H Hua ... Nicolas R Thompson
01 Mar 2019
Effects of multiple sclerosis disease-modifying therapies on employment measures using patient-reported data
Jing Chen ... Leigh Blizzard
Journal of Neurology, Neurosurgery & Psychiatry | VOL. 89
Jing Chen, et. al.Jing Chen ... Leigh Blizzard
19 Jun 2018
View more papers

More From: Journal of Neurology, Neurosurgery & Psychiatry

Paper Title
Journal
Date
Author
Induction cyclophosphamide with maintenance immunosuppression in high-risk myasthenia gravis: long-term follow-up and safety profile
Fiona Chan ... Stephen W Reddel
Journal of Neurology, Neurosurgery & Psychiatry | VOL. -
Fiona Chan, et. al.Fiona Chan ... Stephen W Reddel
04 Jul 2024
Cyclophosphamide for myasthenia gravis: a comeback?
Carolina Barnett-Tapia ... Hans D Katzberg
Journal of Neurology, Neurosurgery & Psychiatry | VOL. -
Carolina Barnett-Tapia, et. al.Carolina Barnett-Tapia ... Hans D Katzberg
04 Jul 2024
Predictors of a relapsing course in myelin oligodendrocyte glycoprotein antibody-associated disease
Akash Virupakshaiah ... Emmanuelle Waubant
Journal of Neurology, Neurosurgery & Psychiatry | VOL. -
Akash Virupakshaiah, et. al.Akash Virupakshaiah ... Emmanuelle Waubant
04 Jul 2024
Identification of a pathogenic mutation in ARPP21 in patients with amyotrophic lateral sclerosis
Oriol Dols-Icardo ... Ricard Rojas-García
Journal of Neurology, Neurosurgery & Psychiatry | VOL. -
Oriol Dols-Icardo, et. al.Oriol Dols-Icardo ... Ricard Rojas-García
02 Jul 2024
View more papers